Beyond structure: Do intermediate filaments modulate cell signalling?

BioEssays

Volumn 24, Issue 9, 2002, Pages 836-844

  Paramio, Jesus M ^a   Jorcano, José L ^a  

^a CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN; VIMENTIN;

ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; CYTOPLASM; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; CELL MEMBRANE; CYTOPLASM; DESMIN; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MODELS, BIOLOGICAL; MODELS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VIMENTIN;

MAMMALIA;

EID: 0036712430     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10140     Document Type: Review

References (91)

1. IFs: Structure, dynamics, function, and disease
2. The 'ins' and 'outs' of IF organization
3. IFs on the move
4. IFs: Molecular architecture, assembly, dynamics and polymorphism
5. IFs and cytoplasmic networking: New connections and more functions
6. Neurofilament functions in health and disease
7. Neurofilament homeostasis and motoneurone degeneration
8. Neuronal IFs
9. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism
10. Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded
11. Lamins in disease: Why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?
12. The dynamics of the nuclear lamins during the cell cycle - Relationship between structure and function
13. The nuclear envelope, muscular dystrophy and gene expression
14. The nuclear lamina: Molecular organization and interaction with chromatin
15. Lamins and lamin-binding proteins in functional chromatin organization
16. A structural scaffolding of IFs in health and disease
17. Human keratin diseases: The increasing spectrum of disease and subtlety of the phenotype-genotype correlation
18. Of mice and men: Genetic disorders of the cytoskeleton
19. The cytoskeleton and disease: Genetic disorders of IFs
20. Disease model: Heritable skin blistering
21. Using transgenic models to study the pathogenesis of keratin-based inherited skin diseases
22. IFs in disease
23. Keratin diseases
24. Modulation of the metastatic capability in B16 melanoma by cell shape
25. Intermediate filaments. Looking for a function
26. Animal cell shape changes and gene expression
27. IFs in motion: Observations of IFs in cells using green fluorescent protein-vimentin
28. Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network
29. Cellular components that functionally interact with signaling phospholipase A(2)s
30. Implications of intermediate filament protein phosphorylation
31. 14-3-3 Proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor
32. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins
33. Vimentin: The conundrum of the IF gene family
34. Mouse vimentin: Structural relationship to fos, jun, CREB and tpr
35. Overexpression of the vimentin gene in transgenic mice inhibits normal lens cell differentiation
36. Mice lacking vimentin develop and reproduce without an obvious phenotype
37. Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice
38. Cerebellar defect and impaired motor coordination in mice lacking vimentin
39. Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts
40. Impaired wound healing in embryonic and adult mice lacking vimentin
41. Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance
42. Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin
43. Role of IFs in migration, invasion and metastasis
44. Experimental co-expression of vimentin and keratin IFs in human breast cancer cells results in phenotypic interconversion and increased invasive behavior
45. Suppression of the chemically transformed phenotype of BHK cells by a human cDNA
46. Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: An approach to study the role of vimentin in tumorigenesis
47. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
48. IF protein partnership in astrocytes
49. Mice lacking glial fibrillary acidic protein display astrocytes devoid of IFs but develop and reproduce normally
50. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice
51. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination
52. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin
53. The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes
54. Role of glial filaments in cells and tumors of glial origin: A review
55. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of IFs and an increased cell saturation density
56. Suppression of glial tumor growth by expression of glial fibrillary acidic protein
57. Desmin cytoskeleton in muscle integrity and function
58. Desmin Cytoskeleton in healthy and failing heart
59. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin
60. Cytoskeletal control of myogenesis: A desmin null mutation blocks the myogenic pathway during embryonic stem cell differentiation
61. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin
62. Cardiovascular lesions and skeletal myopathy in mice lacking desmin
63. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function
64. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle
65. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function
66. Mid-gestational lethality in mice lacking keratin 8
67. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice
68. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin K18 conserved arginine mutant
69. Susceptibility to hepatotoxicity in transgenic mice that express a dominant negative human keratin 18 mutant
70. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis
71. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation
72. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD
73. IFs of the liver: Emerging disease association and functions
74. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression
75. Disturbances in hepatic cell-cycle regulation in mice with assembly-deficient keratins 8/18
76. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion
77. Exocrine pancreatic disorders in transgenic mice expressing human keratin 8
78. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas
79. The functional diversity of epidermal keratins revealed by the partial rescue of the keratin 14 null phenotype by keratin 16
80. The basal keratin network of stratified squamous epithelia: Defining k15 function in the absence of k14
81. Increased expression of keratin K16 causes anomalies in cytoarchitecture and keratinization in transgenic mice
82. Onset of reepithelization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16
83. Directed expression of keratin k16 to the progenitor basal cells of transgenic mouse skin delays skin maturation
84. Modulation of cell proliferation by cytokeratins k10 and k16
85. Delays in malignant Ttumor development in transgenic mice by forced epidermal keratin k10 in mouse skin carcinomas
86. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation
87. The inhibition of Akt/PKB and PKCξ mediates the keratin k10-induced cell cycle arrest
88. Forced expression of keratin 16 alters the adhesion, differentiation and migration of mouse skin keratinocytes
89. Functional roles of Akt signaling in mouse skin tumorigenesis
90. The expression of keratin k10 in the Basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis
91. Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice